ACCESSION: MSBNK-SMB_Measured-HSA001P0099003
RECORD_TITLE: Uncharacterized; LC-ESI-QFT; MS2; POSITIVE; Averaged data
DATE: 2025.04.02 (Averaged 2025.02.14, Processed 2025.02.21, Annotated 2025.04.02, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Shin-MassBank project in preparation
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MB-POST
COMMENT: DATASET_ID MPST000004
COMMENT: DATASET_TITLE Annotation of various metabolites in SRM 1950 human serum
COMMENT: DATASET_AUTHORS Masatomo Takahashi, Yoshihiro Izumi, Kyushu University
COMMENT: MS1_M/Z_AVERAGED_THRES 0.750
COMMENT: MS2_M/Z_AVERAGED_THRES 4.000
COMMENT: DATASET_FILE_NUM 22
COMMENT: NUM_AVERAGED_SPEC 15
COMMENT: RAW_SPEC {'BLK01_1762': {'bp': 250672.0, 'sum': 810513.0}, '9_posi_2033': {'bp': 187188.0, 'sum': 570863.0}, 'ProcedureBlank_1780': {'bp': 181558.0, 'sum': 539170.0}, '18_posi_1784': {'bp': 176803.0, 'sum': 539428.0}, '19_posi_2161': {'bp': 166268.0, 'sum': 527279.0}, '8_posi_2099': {'bp': 164461.0, 'sum': 563421.0}, '12_posi_1972': {'bp': 163161.0, 'sum': 512153.0}, '19_posi_1763': {'bp': 163112.0, 'sum': 570892.0}, '19_posi_1846': {'bp': 156379.0, 'sum': 551177.0}, '13_posi_1784': {'bp': 151434.0, 'sum': 518236.0}, '19_posi_1993': {'bp': 149198.0, 'sum': 512896.0}, '17_posi_1763': {'bp': 146845.0, 'sum': 510649.0}, '9_posi_1783': {'bp': 141977.0, 'sum': 499973.0}, '18_posi_1889': {'bp': 139484.0, 'sum': 460704.0}, '6_posi_1825': {'bp': 126734.0, 'sum': 404763.0}}
COMMENT: RETENTION_TIME_STDEV 0.270
COMMENT: PRECURSOR_M/Z_RAW 99.055500
COMMENT: PRECURSOR_M/Z_STDEV 0.000019
COMMENT: PRECURSOR_IN_MS1 ND
COMMENT: PROPOSED_CHARGE_STATE ND
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.286; C4H6N2O; [M+H]+; delta(ppm) 0.285574
COMMENT: PROPOSED_MF MS-FINDER 3.868; C4H6N2O; [M+H]+; delta(ppm) 0.280045
COMMENT: PROPOSED_MF SIRIUS6_Sirius 16.719; C4H6N2O; [M+H]+; delta(ppm) 0.280045
COMMENT: PROPOSED_MF SIRIUS6_Sirius -4.314; C2H4N5; [M+H]+; delta(ppm) 13.834921
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C4H6N2O; [M+H]+; delta(ppm) 0.280045
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.857; SDFAQCKICUGIJO-UHFFFAOYSA-N; [M+H]+; CC1=NCNC1=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.778; NHLAPJMCARJFOG-UHFFFAOYSA-N; [M+H]+; CC1=NN=C(O)C1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.556; QDYTUZCWBJRHKK-UHFFFAOYSA-N; [M+H]+; OCC1=CNC=N1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.533; FKPXGNGUVSHWQQ-UHFFFAOYSA-N; [M+H]+; CC1=CC(=N)NO1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.533; YVDWFZIVIIKYBQ-UHFFFAOYSA-N; [M+H]+; N=1N=C(OC1C)C
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.089; JRMKJOOJKCAEJK-UHFFFAOYSA-N; [M+H]+; 4-Hydroxymethylpyrazole
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.002; YVDWFZIVIIKYBQ-UHFFFAOYSA-N; [M+H]+; dimethyl-1,3,4-oxadiazole
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.962; SDFAQCKICUGIJO-UHFFFAOYSA-N; [M+H]+; Pelopuradazole
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.943; QDYTUZCWBJRHKK-UHFFFAOYSA-N; [M+H]+; imidazole-4-methanol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.933; LIHUTSFYFGCWQP-UHFFFAOYSA-N; [M+H]+; 2-cyano-N-methylacetamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.933; NHLAPJMCARJFOG-UHFFFAOYSA-N; [M+H]+; 2,4-dihydro-5-methyl-3H-pyrazol-3-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.916; FKPXGNGUVSHWQQ-UHFFFAOYSA-N; [M+H]+; 3-Isoxazolamine (Int.3)
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.896; LMDDHEQEFKCAJH-SGAVLPGINA-N; [M+H]+; UNPD98235
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.829; ONONIESHMTZAKB-UHFFFAOYNA-N; [M+H]+; N-(1-cyanoethyl)formamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; SDFAQCKICUGIJO-UHFFFAOYSA-N; [M+H]+; Pelopuradazole
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.691; NHLAPJMCARJFOG-UHFFFAOYSA-N; [M+H]+; 2,4-dihydro-5-methyl-3H-pyrazol-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.584; LMDDHEQEFKCAJH-SGAVLPGINA-N; [M+H]+; UNPD98235
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.541; JRMKJOOJKCAEJK-UHFFFAOYSA-N; [M+H]+; 4-Hydroxymethylpyrazole
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.541; QDYTUZCWBJRHKK-UHFFFAOYSA-N; [M+H]+; imidazole-4-methanol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.145; FKPXGNGUVSHWQQ-UHFFFAOYSA-N; [M+H]+; 3-Isoxazolamine (Int.3)
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.098; YVDWFZIVIIKYBQ-UHFFFAOYSA-N; [M+H]+; dimethyl-1,3,4-oxadiazole
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; LIHUTSFYFGCWQP-UHFFFAOYSA-N; [M+H]+; 2-cyano-N-methylacetamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; ONONIESHMTZAKB-UHFFFAOYNA-N; [M+H]+; N-(1-cyanoethyl)formamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.130; QDYTUZCWBJRHKK-UHFFFAOYSA-N; [M+H]+; 1H-imidazol-5-ylmethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.526; FKPXGNGUVSHWQQ-UHFFFAOYSA-N; [M+H]+; 5-methyl-1,2-oxazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.476; NHLAPJMCARJFOG-UHFFFAOYSA-N; [M+H]+; 3-methyl-1,4-dihydropyrazol-5-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.668; WGVHNCAJPFIFCR-UHFFFAOYSA-N; [M+H]+; 5-methyl-1,2-dihydropyrazol-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.553; ZOMATQMEHRJKLO-UHFFFAOYSA-N; [M+H]+; 1H-imidazol-2-ylmethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.478; JMARSTSWTFXHMC-UHFFFAOYSA-N; [M+H]+; 2-methyl-1H-pyrazol-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.375; NNZXDXMEXBYSRF-UHFFFAOYSA-N; [M+H]+; 2-methyl-4H-pyrazol-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.333; GFLJNYQMIIBKIE-UHFFFAOYSA-N; [M+H]+; 2-(3-methyldiazirin-3-yl)acetaldehyde
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.324; JRMKJOOJKCAEJK-UHFFFAOYSA-N; [M+H]+; 1H-pyrazol-4-ylmethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.181; MCSCIFLXNFLCDV-UHFFFAOYSA-N; [M+H]+; 4-methyl-1,3-dihydroimidazol-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.154; VCZJVXLWQTXSPQ-UHFFFAOYSA-N; [M+H]+; 4-methyl-1,3-oxazol-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.123; NRYCMMCUURADTR-UHFFFAOYSA-N; [M+H]+; 1,2-oxazol-3-ylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.119; UVEDQUMYFTWIPC-UHFFFAOYSA-N; [M+H]+; N-methyl-1,2-oxazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.111; IENISVMEYSGVOI-UHFFFAOYSA-N; [M+H]+; 4-methyl-1,2-oxazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.107; PXHFWPOPKVWXQT-UHFFFAOYSA-N; [M+H]+; 3-methyl-1H-imidazol-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.094; YWXMEOHQQJWIOZ-UHFFFAOYSA-N; [M+H]+; N-methyl-1,3-oxazol-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.079; YVDWFZIVIIKYBQ-UHFFFAOYSA-N; [M+H]+; 2,5-dimethyl-1,3,4-oxadiazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.073; UIEABCXJWANXFS-UHFFFAOYSA-N; [M+H]+; 1H-pyrazol-5-ylmethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.065; ZLKZGKDNYHEPFV-UHFFFAOYSA-N; [M+H]+; 1,3-oxazol-2-ylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.032; WIISOYLZJJYTHT-UHFFFAOYSA-N; [M+H]+; 2-methyl-1H-pyrazol-5-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.018; ULZXEYFKBUPRQM-UHFFFAOYSA-N; [M+H]+; 1,3-oxazol-4-ylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.006; OKFHTQFXGQXDEX-UHFFFAOYSA-N; [M+H]+; 1-nitroso-2,5-dihydropyrrole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.000; BNOWDJRGXLVJHD-UHFFFAOYSA-N; [M+H]+; 3-methyl-1,2-oxazol-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.985; ZPIDZCBCCUTEEI-UHFFFAOYSA-N; [M+H]+; 1,3-oxazol-5-ylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.981; XETGVWXXGWZBDG-UHFFFAOYSA-N; [M+H]+; 1,2-oxazol-4-ylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.950; GWYFIIHULJCWMO-UHFFFAOYSA-N; [M+H]+; 4-methyl-1,4-dihydropyrazol-5-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.936; FNXYWHTZDAVRTB-UHFFFAOYSA-N; [M+H]+; 3-methyl-1,2-oxazol-5-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.933; NJZGUJMVUBUAOC-UHFFFAOYSA-N; [M+H]+; 2-methyl-1,3-oxazol-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.924; FQASUNMXKLPOOF-UHFFFAOYSA-N; [M+H]+; 1-methylpyrazol-4-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.902; LJPYJRMMPVFEKR-UHFFFAOYSA-N; [M+H]+; prop-2-ynylurea
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.886; RGQMPSRGRDKMCX-UHFFFAOYSA-N; [M+H]+; 5-methyl-1H-pyrazol-4-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.875; LMDDHEQEFKCAJH-UHFFFAOYSA-N; [M+H]+; 5-amino-2H-pyrrol-2-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.714; LILTZUFNZDRURN-UHFFFAOYSA-N; [M+H]+; methyl N-cyanoethanimidate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.601; LIHUTSFYFGCWQP-UHFFFAOYSA-N; [M+H]+; 2-cyano-N-methylacetamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.519; DYYFCNDEROYKKJ-UHFFFAOYSA-N; [M+H]+; 5-methyl-1,3-oxazol-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.492; QGMHRTDVNDXDBB-UHFFFAOYSA-N; [M+H]+; 5-methyl-1,2-oxazol-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.486; JKJSZGJVBAWEFB-UHFFFAOYSA-N; [M+H]+; 3,4-dimethyl-1,2,5-oxadiazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.472; NCFMDIJKEYGCRD-UHFFFAOYSA-N; [M+H]+; 4-methoxy-1H-pyrazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.465; OYNWFDBANWIYDA-UHFFFAOYSA-N; [M+H]+; 1,2-oxazol-5-ylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.447; RFOKQRIAAPEYBE-UHFFFAOYSA-N; [M+H]+; 3-aminooxetane-3-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.429; GYNLTWUPSJGXFV-UHFFFAOYSA-N; [M+H]+; 4-methyl-1,2-oxazol-5-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.419; MWIGGUZSIJZLJM-UHFFFAOYSA-N; [M+H]+; ethyl N-cyanomethanimidate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.402; DASYJICSSLWYAG-UHFFFAOYSA-N; [M+H]+; 2-cyanopropanamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.399; ZGSNZVRXASCXRP-UHFFFAOYSA-N; [M+H]+; 5-methoxy-1H-pyrazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.386; LHWCUMYXUCPQSZ-UHFFFAOYSA-N; [M+H]+; N-(cyanomethyl)acetamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.381; YXSUIVZFLAJASX-UHFFFAOYSA-N; [M+H]+; 5-methoxy-1H-imidazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.352; ONONIESHMTZAKB-UHFFFAOYSA-N; [M+H]+; N-(1-cyanoethyl)formamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.334; VIAULTBEPNVQAG-UHFFFAOYSA-N; [M+H]+; 3-hydroxyazetidine-1-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.333; UANYAJXOOSFGOM-UHFFFAOYSA-N; [M+H]+; 3-hydroxyazetidine-3-carbonitrile
COMMENT: CONFIDENCE Level 4: Unequivocal precursor ion formula C4H7N2O1; Top hit by both SIRIUS6_Zodiac and MS-FINDER; and SevenGoldenRules(1);
CH$NAME: Uncharacterized
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Serum
AC$INSTRUMENT: Nexera X2 UHPLC system, Shimadzu - Q Exactive Orbitrap, Thermo Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY 20 V
AC$MASS_SPECTROMETRY: COLLISION_GAS N2
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 0.75; MS2(ppm) 4.00
AC$CHROMATOGRAPHY: COLUMN_NAME GL-HilicAex 2.1 x 150 mm, 5 mm (Resonac)
AC$CHROMATOGRAPHY: FLOW_GRADIENT B conc(%). 0 min: 95, 0.5 min: 95, 15.5 min: 40, 16.5 min: 0, 26.5 min: 0, 27.5 min: 95, 35 min: 95.
AC$CHROMATOGRAPHY: FLOW_RATE 0.4 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 3.776
MS$FOCUSED_ION: PRECURSOR_M/Z 99.055317
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-006t-9000000000-dbbe609de2091678f264
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  56.0495570 70.5325 56.050189 1.8198 13.53 0.4000 15 f{C3H6N1}/1.45ppm,p-C1H1N1O1
  57.0447720 30.3037 57.045406 1.1395 8.79 0.5429 15 f{C2H5N2}/0.83ppm,p-C2H2O1
  58.0651492 58.4314 58.065785 1.3778 15.70 0.2036 15 ?
  69.0447431 346.1250 69.045369 0.3476 46.96 0.2214 15 f{C3H5N2}/0.27ppm,p-C1H2O1
  70.0651438 145.0704 70.065763 0.7422 29.17 0.3036 15 ?
  71.0603941 999.0000 71.061007 0.1970 0.00 0.8393 15 f{C3H7N2}/0.27ppm,p-C1O1
  81.0446669 50.6891 81.045193 1.1722 13.92 -0.0429 15 f{C4H5N2}/-0.71ppm,p-H2O1
  82.0480234 54.5763 82.048539 0.6703 10.97 0.3143 15 ?
  82.0651109 90.9858 82.065626 0.9505 33.45 0.3857 15 ?
  84.0682063 29.5096 84.068698 1.9270 7.23 0.7643 15 ?
  99.0553366 820.6585 99.055666 0.2726 50.09 1.0000 15 f{C4H7N2O1}/0.48ppm,p
  99.0743950 59.9971 99.074724 3.7548 19.34 0.1912 14 ?
  99.0917069 368.0575 99.092036 0.4541 39.25 0.5964 15 ?
PK$NUM_PEAK: 13
PK$PEAK: m/z int. rel.int.
  56.049557 70.53 70
  57.044772 30.30 30
  58.065149 58.43 58
  69.044743 346.12 346
  70.065144 145.07 145
  71.060394 999.00 999
  81.044667 50.69 50
  82.048023 54.58 54
  82.065111 90.99 90
  84.068206 29.51 29
  99.055337 820.66 820
  99.074395 60.00 59
  99.091707 368.06 368
//
